Osimertinib generic drug price list in 2024
Osimertinib, as a highly effective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), is developed and produced by AstraZeneca in the UK. It is one of the representatives of the third generation of targeted anti-cancer drugs. It is mainly used to treat patients with non-small cell lung cancer (NSCLC) carrying EGFR mutation genes. By precisely targeting and inhibiting the activity of EGFR receptors, it effectively blocks the growth signals of tumor cells, thereby prolonging the patient's survival and significantly improving the quality of life. However, the high price of original drugs often prohibits many patients. Fortunately, with the continuous development of the generic drug market, multiple manufacturers have launched generic versions of osimertinib, providing patients with more economical treatment options.
In Laos, manufacturers such as Lucius Pharmaceuticals, United Pharmaceuticals, Second Pharmaceutical Factory and ASEAN Pharmaceuticals all produce generic drugs of osimertinib. The specifications of these generic drugs are unified as 80mg*30 tablets, and the price of a box is roughly between 500 and 600 to 600 and 700 yuan. Compared with the high prices of original drugs, these generic drugs undoubtedly reduce the financial burden on patients, allowing more patients to afford this important treatment.

In addition to the Lao generic version, other versions of osimertinib are available in the Bangladeshi market. For example, the Osimertinib version produced by Yaopin International, Incepta Pharmaceuticals and Everest Pharmaceuticals has the same specifications of 80mg*30 tablets and sells for about 800 to 900 RMB per box. Although the price of these versions is slightly higher than the generic drugs in Laos, they still have a significant price advantage compared to the original drugs. In addition, Bican version of osimertinib can also be found in the Bangladeshi market. The specifications of this version of the medicine are consistent with other versions, namely 80mg*30 tablets, but the price is relatively high, about more than 2,000 yuan per box. Although the Beacon version is more expensive, it may still be an option worth considering for certain patients.
However, special reminder is that there are many risks involved in purchasing drugs overseas. When patients purchase generic osimertinib drugs, they must purchase them through formal and legal channels to ensure the quality and safety of the drugs. At the same time, patients should also consult a professional doctor or pharmacist for advice before using generic drugs to understand the indications, usage and dosage, and possible side effects of the drug.
To sum up, the price of osimertinib generic drugs in2024 will show a diversified trend, with differences in prices between different manufacturers and versions. When making a choice, patients should make comprehensive considerations based on their financial status and medical needs. At the same time, you must remain vigilant and avoid purchasing drugs through illegal channels to avoid unnecessary risks to your health.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)